Диабетическая нейроостеоартропатия: современные подходы к диагностике и определению сроков иммобилизации (обзор)

Диабетическая нейроостеоартропатия - осложнение сахарного диабета, ассоциированное с высокой частотой ампутаций и уровнем смертности. Благодаря развитию методов диагностики сегодня стало возможным выявление диабетической нейроостеоартропатии на ранней рентген-негативной стадии. Лечение на данном этапе способно предотвратить развитие выраженной деструкции костного скелета стопы и формирование серьезных деформаций. Однако не существует единого подхода к диагностике рентген-негативной стадии диабетической нейроостеоартропатии. Также остается спорным вопрос о сроках иммобилизации пораженной конечности и методах определения завершения острой стадии диабетической нейроостеоартропатии. Данный обзор посвящен современному состоянию знаний о диагностике, классификации и критериях завершения активной стадии диабетической нейроостеоартропатии.

сахарный диабет, стопа Шарко, ранняя диагностика, МРТ

1. Chisholm KA, Gilchrist JM. The Charcot joint: A modern neurologic perspective. J Clin Neuromuscul Dis. 2011;13(1): 1-13. doi: 10.1097/CND.0b013e3181c6f55b.

2. Slater RA, Ramot Y, Buchs A, et al. The diabetic Сharcot foot. Isr Med Assoc J. 2004;6(5):280-283.

3. Pakarinen T-K, Laine H-J, Mäenpää H, et al. Long-term outcome and quality of life in patients with Сharcot foot. Foot Ankle Surg. 2009;15(4):187-191. doi: 10.1016/j.fas.2009.02.005.

4. Sella EJ, Barrette C. Staging of Сharcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. 1999;38(1):34-40. doi: 10.1016/s1067-2516(99)80086-6.

5. Edmonds M, Petrova N, Edmonds A, et al. What happens to the initial bone marrow oedema in the natural history of Сharcot osteoarthropathy. Diabetologia. 2006;49(Suppl 1):684.

6. Chantelau E, Richter A. The acute diabetic Сharcot foot managed on the basis of magnetic resonance imaging - a review of 71 cases. Swiss Med Wkly. 2013. doi: 10.4414/smw.2013.13831.

7. Ruotolo V, Di Pietro B, Giurato L, et al. A new natural history of Сharcot foot. Clin Nucl Med. 2013;38(7):506-509. doi: 10.1097/RLU.0b013e318292eecb.

8. Bolacchi F, Uccioli L, Masala S, et al. Proton magnetic resonance spectroscopy in the evaluation of patients with acute Сharcot neuro-osteoarthropathy. Eur Radiol. 2013;23(10): 2807-2813. doi: 10.1007/s00330-013-2894-y.

9. Greenstein AS, Marzo-Ortega H, Emery P, et al. Magnetic resonance imaging as a predictor of progressive joint destruction in neuropathic joint disease. Arthritis Rheum. 2002;46(10):2814-2815. doi: 10.1002/art.10532.

10. Valabhji J. Immunosuppression therapy posttransplantation can be associated with a different clinical phenotype for diabetic Сharcot foot neuroarthropathy. Diabetes Care. 2011;34(8):e135-e135. doi: 10.2337/dc11-0960.

11. Kimmerle R, Chantelau E. Weight-bearing intensity produces Сharcot deformity in injured neuropathic feet in diabetes. Exp Clin Endocrinol Diabetes. 2007;115(6):360-364. doi: 10.1055/s-2007-970578.

12. Sanders L, Frykberg R. Diabetic neuropathic osteoarthropathy: The Сharcot foot. In: Frykberg RG, editor. The high risk foot in diabetes mellitus. 1991. p.325-333.

13. Rajbhandari SM, Jenkins RC, Davies C, et al. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45(8):1085-1096. doi: 10.1007/s00125-002-0885-7.

14. Sinacore DR, Withrington NC. Recognition and management of acute neuropathic (Сharcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther. 1999;29(12):736-746. doi: 10.2519/jospt.1999.29.12.736.

15. Edmonds M, Watkins P. The Сharcot joint: Understanding its natural history leads to new treatment and prevention. Abstract. Diabet Med. 1984;1:144A.

16. Shibata T, Tada K, Hashizume C. The results of arthrodesis of the ankle for leprotic neuroarthropathy. J Bone Joint Surg Am. 1990;72(5):749-756.

17. Rogers LC, Frykberg RG, Armstrong DG, et al. The Сharcot foot in diabetes. Diabetes Care. 2011;34(9):2123-2129. doi: 10.2337/dc11-0844.

18. Petrova NL, Moniz C, Elias DA, et al. Is there a systemic inflammatory response in the acute Сharcot foot? Diabetes Care. 2007;30(4):997-998. doi: 10.2337/dc06-2168.

19. Rogers LC, Bevilacqua NJ. Imaging of the Сharcot foot. Clin Podiatr Med Surg. 2008;25(2):263-274. doi: 10.1016/j.cpm.2008.01.002.

20. Andersen LB, Dipreta J. Charcot of the calcaneus. Foot Ankle Clin. 2006;11(4):825-835. doi: 10.1016/j.fcl.2006.06.010.

21. Morrison WB, Ledermann HP. Work-up of the diabetic foot. Radiol Clin North Am. 2002;40(5):1171-1192. doi: 10.1016/s0033-8389(02)00036-2.

22. Chantelau E, Poll L. Evaluation of the diabetic Сharcot foot by mr imaging or plain radiography - an observational study. Exp Clin Endocrinol Diabetes. 2006;114(8):428-431. doi: 10.1055/s-2006-924229.

23. Loredo R, Rahal A, Garcia G, et al. Imaging of the diabetic foot diagnostic dilemmas. Foot & Ankle Specialist. 2010;3(5): 249-264. doi: 10.1177/1938640010383154.

24. Sartoris DJ. Cross-sectional imaging of the diabetic foot. J Foot Ankle Surg. 1994;33(6):531-545.

25. Edmonds ME, Edmonds A, Elias D, et al. CT scans reveal the full extent of bone and joint damage of the Charcot foot. Abstract. Diabet Med. 2010;27 (Suppl 1):18.

26. Keenan AM. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med. 1989;149(10):2262. doi: 10.1001/archinte.1989.00390100078019.

27. Schauwecker DS. The scintigraphic diagnosis of osteomyelitis. Am J Roentgenol. 1992;158(1):9-18. doi: 10.2214/ajr.158.1.1727365.

28. Tomas MB, Patel M, Marwin SE, et al. The diabetic foot. Br J Radiol. 2000;73(868):443-450. doi: 10.1259/bjr.73.868.10844873.

29. Basu S, Zhuang H, Alavi A. Imaging of lower extremity artery atherosclerosis in diabetic foot. Clin Nucl Med. 2007;32(7): 567-568. doi: 10.1097/RLU.0b013e3180646ac0.

30. Hopfner S, Krolak C, Kessler S, et al. Preoperative imaging of Сharcot neuroarthropathy in diabetic patients: Comparison of ring pet, hybrid pet, and magnetic resonance imaging. Foot Ankle Int. 2004;25(12):890-895.

31. Pickwell KM, Van Kroonenburgh MJ, Weijers RE, et al. F-18 fdg pet/ct scanning in Сharcot disease. Clin Nucl Med. 2011;36(1):8-10. doi: 10.1097/RLU.0b013e3181feeb30.

32. Tins BJ, Cassar-Pullicino VN. Non-infective inflammatory bone marrow disease. In: Baur-Melnyk A, editor. Magnetic resonance imaging of the bone marrow. Springer; 2012. p. 311-335.

33. Krüger K, Heindel W, Burger C, et al., editors. Mr-tomographische darstellung der unkomplizierten, sekundären frakturheilung am beispiel der distalen radiusfraktur. RÖFO. Fortschritte auf dem Gebiete der Röntgenstrahlen und der neuen bildgebenden Verfahren; 1999: Thieme.

34. Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol. 2012;8(3):133-143. doi: 10.1038/nrrheum.2012.1.

35. Ledermann HP, Morrison WB. Differential diagnosis of pedal osteomyelitis and diabetic neuroarthropathy: Mr imaging. Semin Musculoskelet Radiol. 2005;09(03):272-283. doi: 10.1055/s-2005-921945.

36. Marcus CD, Ladam-Marcus VJ, Leone J, et al. Mr imaging of osteomyelitis and neuropathic osteoarthropathy in the feet of diabetics. Radiographics. 1996;16(6):1337-1348. doi: 10.1148/radiographics.16.6.8946539.

37. Zampa V, Bargellini I, Rizzo L, et al. Role of dynamic mri in the follow-up of acute Сharcot foot in patients with diabetes mellitus. Skeletal Radiol. 2011;40(8):991-999. doi: 10.1007/s00256-010-1092-0.

38. Vanhoenacker FM, Eyselbergs M, Demeyere A. Bone marrow changes in acute and chronic trauma. In: Baur-Melnyk A, editor. Magnetic resonance imaging of the bone marrow. Springer; 2012. p. 265-292.

39. Schmid MR, Hodler J, Vienne P, et al. Bone marrow abnormalities of foot and ankle: Stir versus t1-weighted contrast-enhanced fat-suppressed spin-echo mr imaging. Radiology. 2002;224(2):463-469. doi: 10.1148/radiol.2242011252.

40. Chantelau EA, Grutzner G. Is the Eichenholtz classification still valid for the diabetic Charcot foot? Swiss Med Wkly. 2014;144:w13948. doi: 10.4414/smw.2014.13948.

41. Gazis A, Pound N, Macfarlane R, et al. Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot). Diabet Med. 2004;21(11):1243-1246. doi: 10.1111/j.1464-5491.2004.01215.x.

42. Osterhoff G, Boni T, Berli M. Recurrence of acute Charcot neuropathic osteoarthropathy after conservative treatment. Foot Ankle Int. 2013;34(3):359-364. doi: 10.1177/1071100712464957.

43. Демина А.Г., Бреговский В.Б., Карпова И.А. Критерии продолжительности иммобилизации пораженной конечности при диабетической нейроостеоартропатии Шарко. // Сахарный диабет. - 2014. - Т. 17. - №4 - С.60-65. [Demina AG, Bregovskiy VB, Karpova IA. Criteria of immobilization duration of the affected foot in diabetic Charcot neuro-osteoarthropathy. Diabetes mellitus. 2014; 17(4):60-65. (In Russ).] doi: 10.14341/dm2014460-65.

44. Goodridge D, Trepman E, Sloan J, et al. Quality of life of adults with unhealed and healed diabetic foot ulcers. Foot Ankle Int. 2006;27(4):274-280.

45. Nabuurs-Franssen MH, Huijberts MSP, Nieuwenhuijzen Kruseman AC, et al. Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia. 2005;48(9):1906-1910. doi: 10.1007/s00125-005-1856-6.

46. Pinzur MS, Evans A. Health-related quality of life in patients with Charcot foot. Am J Orthop (Belle Mead NJ). 2003;32(10):492-496.

47. Willrich A, Pinzur M, McNeil M, et al. Health related quality of life, cognitive function, and depression in diabetic patients with foot ulcer or amputation. A preliminary study. Foot Ankle Int. 2005;26(2):128-134.

48. Van Adrichem RA, Debeij J, Nelissen RGHH, et al. Below-knee cast immobilization and the risk of venous thrombosis: Results from a large population-based case-control study. J Thromb Haemost. 2014;12(9):1461-1469. doi: 10.1111/jth.12655.

49. Moura-Neto A, Fernandes TD, Zantut-Wittmann DE, et al. Charcot foot: Skin temperature as a good clinical parameter for predicting disease outcome. Diabetes Res Clin Pract. 2012;96(2):e11-e14. doi: 10.1016/j.diabres.2011.12.029.

50. McCrory JL, Morag E, Norkitis AJ, et al. Healing of Charcot fractures: Skin temperature and radiographic correlates. The Foot.1998;8(3):158-165. doi: 10.1016/s0958-2592(98)90052-9.

51. McGill M, Molyneaux L, Bolton T, et al. Response of charcot's arthropathy to contact casting: Assessment by quantitative techniques. Diabetologia. 2000;43(4):481-484. doi: 10.1007/s001250051332.